Chapter Category: Cell Cycle

From the book Cell Cycle Checkpoints and Cancer

The Regulation of p53 Growth Suppression

Ronit Vogt Sionov, Igal Louria Hayon, Ygal Haupt

The p53 tumor suppressor protein plays a pivotal role in the cellular response to stress. A variety of stress signals trigger accumulation and activation of p53 to halt the cell cycle and to prevent replication of damaged DNA. The p53 protein is required for a proper G1 arrest, it is essential for maintaining the G2 arrest, and it contributes to the mitotic spindle checkpoint. p53 exerts these actions by inducing multiple target genes. Under defined conditions, p53 induces programmed cell death by mechanisms that are partially understood and involve a combination of transcriptional-dependent and —independent activities. The choice between arrest and cell death depends on the final integration of antagonistic signals. These include the type and intensity of the stress signal, the spectrum \r\nof the target genes induced, the type of cell and its oncogenic status, and the \r\npresence of growth and survival factors. The stability of the p53 protein and \r\nits activities are tightly regulated by many factors among which the Mdm2 proto-oncoprotein is the central player. Inhibitory effects of Mdm2 on p53 stability and activities are modulated by multiple mechanisms including post-translational modifications of p53 and Mdm2 and by other interacting proteins. Importantly, p53 is also regulated at the level of its sub-cellular localization. Sequestration of p53 into the cytoplasm is sufficient for its inhibition. In contrast, accumulation of p53 in the nucleus induces its transcriptional activity. This activity can be further enhanced by specific post-translational modifications and by recruitment of p53 into nuclear bodies. We discuss current views on the regulation of p53 and its growth inhibitory activities.

Taken from the book

Cell Cycle Checkpoints and Cancer

Edited by: Ronit Vogt Sionov, Igal Louria Hayon, Ygal Haupt

More chapters from the book:

Signal Transduction Pathways: Cytokine Model
J. A. McCubrey, William L. Blalock, Fumin Chang,

Growth factors (GF) initiate and maintain transition through G1 to S phase. GF-dependence ends with phosphorylation of Rb by cyclin-dependent kinases (CDKs), enabling cells to pass through the restriction (R) point and to complete the remaining phases of the cell cycle. Cyclin D-dependent...


The Restriction Point of the Cell Cycle
Mikhail V. Blagosklonny and Arthur B. Pardee

TGrowth factors (GF) initiate and maintain transition through G1 to S phase. GF-dependence ends with phosphorylation of Rb by cyclin-dependent kinases (CDKs), enabling cells to pass through the restriction (R) point and to complete the remaining phases of the cell cycle. Cyclin D-dependent kinase...


DNA Damage, Cell Cycle Control, and Cancer
Jens Oliver, Temesgen Samuel and H. Oliver Weber

Cell cycle checkpoints constitute a network of signal transduction mechanisms to monitor DNA damage and regulate progression through the cell cycle. A series of events is triggered in cells upon DNA damage. Here we describe a framework for the understanding of the functions of the core components...


The Regulation of p53 Growth Suppression
Ronit Vogt Sionov, Igal Louria Hayon, Ygal Haupt

The p53 tumor suppressor protein plays a pivotal role in the cellular response to stress. A variety of stress signals trigger accumulation and activation of p53 to halt the cell cycle and to prevent replication of damaged DNA. The p53 protein is required for a proper G1 arrest, it is essential...


Functional Interactions Between BRCA1 and the Cell Cycle
Timothy K. MacLachlan and Wafik El-Deiry

The onset of breast cancer in women is one of the most devastating diseases known today, afflicting approximately one in nine women in Western countries. In families that inherit breast and ovarian cancer, BRCA1 mutations account for close to 100% of resultant cancers, and in pedigrees that...


Hypoxia and Cell Cycle
Rachel A. Freiberg, Susannah L. Green and Amato J. Giaccia

Tumor initiation is dependent on several key changes in the requirements for cell growth. Three of the most important features that distinguish transformed cells from untransformed cells are the loss of senescence, anchorage independent growth, and loss of contact inhibition. Cells that adopt a...


G2 Checkpoint and Anticancer Therapy
Zoe A. Stewart and Jennifer A. Pietenpol

Over the past two decades, the basic molecular events controlling eukaryotic G2 to M-phase cell cycle transition have been deciphered. Studies in a variety of organisms have identified an evolutionarily conserved system for controlling mitotic onset through regulation of Cdc2 kinase activity....


p53, Apoptosis, and Cancer Therapy
Rosandra Kaplan and David E. Fisher

Several decades of genetic and molecular study have revealed enormous insights into the mechanistic underpinnings of cancer. From the identification of dominantly acting oncogenes to the signaling pathways which modulate the cell cycle, our understanding of the machinery of cell cycle progression...


Chemotherapeutic drugs and radiation inhibit tumor cell proliferation by inducing growth arrest and cell death. The best-studied antiproliferative response to anticancer agents is programmed cell death or apoptosis. Inhibition of apoptosis, however, has been frequently found to have little or no...


Cyclin-dependent kinases (cdks) are core components of the cell cycle machinery. Orderly transition between cell cycle phases requires the scheduled activity of the cdks, governed in part by their associations with cyclins and cdk inhibitors, as well as by their state of phosphorylation. In...


There have emerged, within the aberrant cell cycle regulatory pathways frequently encountered in cancer cells, several potential targets for novel anticancer drug discovery. Cyclin-dependent kinases (CDKs) and their regulatory units, cyclins, play a central role in cell cycle progression, and...


Autocrine Transformation: Cytokine Model
James A. McCubrey, Xiao-yang Wang, Paul A. Algate, William L. Blalock and Linda S. Steelman

Autocrine growth factor secretion by cells is a frequent event involved in malignant transformation. Constitutive growth factor gene expression can in turn result in the deregulation of survival. Furthermore, autocrine and paracrine growth factor synthesis can also contribute to the enhanced...


The Role of FHIT in Carcinogenesis
Yuri Pekarsky, Kay Huebner and Carlo M. Croce

Tumor suppressor genes and oncogenes can be identified by positions of chromosomal translocations (in leukemia and lymphomas) and by detection of homozygous deletions and loss of heterozygosity (in solid tumors). Using these approaches, we identified a specific locus from the short arm of...


DNA-Damage-Independent Checkpoints from Yeast to Man
Duncan J. Clarke, Adrian P.L. Smith and Juan F. Gimenez-Abian

Checkpoints are mechanisms that establish dependence relationships between biochemically unrelated cellular processes. The temporal order of many critical cell cycle events must be strictly maintained to ensure cell survival and integrity. A simple example is that of genome duplication which must...


Advertisements